Thrombosis
News
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.
Clinical
Shorter vs. longer DAPT following coronary stent placement
Is 6 months of dual antiplatelet therapy (DAPT) therapy noninferior to 12 months, following ST-elevation myocardial infarction (STEMI) with...
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
News
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
News
Rivaroxaban tied to higher GI bleeding than other NOACs
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
All Content
Subsegmental PEs overtreated despite link with patient harm
How often are physicians treating isolated subsegmental pulmonary embolisms?
All Content
Posthospitalization thromboprophylaxis with rivaroxaban is unnecessary
Do symptomatic venous thromboembolism (VTE) complications improve with posthospitalization thromboprophylaxis using rivaroxaban for an at-risk...
Clinical
Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous...
Latest News for HOSP
IVC filter placement increases mortality in some VTE patients
How does inferior vena cava (IVC) filter placement affect 30-day mortality in patients with venous thromboembolism (VTE) with increased risk of...
News
Ticagrelor reversal agent looks promising
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.